PFKL Antibodies

Santa Cruz Biotechnology provides a broad selection of PFKL monoclonal antibodies for investigating phosphofructokinase, liver type (PFKL) in various biological processes. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PFKL is a key enzyme in the glycolytic pathway, playing a crucial role in regulating glucose metabolism and energy production in liver cells. PFKL activity maintains metabolic homeostasis, and its dysregulation has been implicated in various metabolic disorders and diseases. Understanding PFKL function and regulation is essential for advancing research in metabolic diseases and developing potential therapeutic strategies. Researchers can explore glucose metabolism mechanisms through precise PFKL detection and analysis. PFKL monoclonal antibodies enable detailed investigation of metabolic pathways and cellular energy processes. Current studies of PFKL continue to reveal new insights into metabolic regulation and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies for PFKL support breakthrough discoveries in metabolic research and therapeutic development.